NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/05/2024
Voltar para busca
Dado oficial do USPTO
NOVOCOL PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NOVOCOL PHARMA
ST13
US500000088221050Classe
5, 10, 35, 40, 42, 45
Pedido
88221050
Registro
7390115
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
62
Atualização mais recente
03/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 40, 42, 45
Data de depósito
07/12/2018
Data de registro
21/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/05/2024
Última transação
03/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Saint-Maur-des fosses, FR
Examinador
FATHY, DOMINIC
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Septodont Holding SAS
Representantes
JASON J. MAZUR ARENTFOX SCHIFF LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 40Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationsacne medicationallergy medicationantacidsanthelminticsantiarrhythmicsantibiotic creams and ointmentsantibioticsanticoagulantsanticonvulsantsantidepressantsantiemeticsantiflatulantsantihistaminesantihypertensives anti-infectivesanti-inflammatoriesantiparasitesantiviralsburn relief medicationcalcium channel blockerscentral nervous system depressantscentral nervous system stimulantscough treatment medicationdiarrhea medicationfungal medicationsgastro-intestinal pharmaceutical preparationsglaucoma agentshydrocortisonehypnotic agentssedativespain relief medicationtopical and injectable pharmaceutical preparations for dentalendodontic and periodontal disorders; anti-epileptic pharmaceutical preparations; bismuth preparations for pharmaceutical use; bromine for pharmaceutical purposes; cardiovascular pharmaceutical preparations; frostbite salve for pharmaceutical purposes; guaiacol for pharmaceutical purposes; intravenous fluids used for rehydrationnutrition and the delivery of pharmaceutical preparations; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; injectable pharmaceutical contraceptives; pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical hormonal preparationscorticosteroidshormone replacement therapy preparationsoral contraceptivesthyroid hormone preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of bacterial skin infectionsfungal skin infectionsviral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of degenerative nerve diseases and disordersAlzheimer's diseaseParkinson's diseaseHuntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of diseasesdisorders and infections of the endocrine systemgrowth and thyroid disorders; pharmaceutical preparations for the treatment of diseasesdisorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseasesdisorders and infectionsinfertilitysexually transmitted diseasesincontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseasesurological diseasesinfertilitysexually transmitted diseasesinflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immunologic diseasesautoimmune diseasesimmunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseasesrespiratory infectionseye infections; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseasesinflammatory bowel diseasesinflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disordersgoutosteoarthritismuscular dystrophyanemia; pharmaceutical preparations for the treatment of metabolic disordersbulimia nervosaanorexiahypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseasesAlzheimer'sHuntington's Diseasecerebral palsy; pharmaceutical preparations for the treatment of neurological disordersbrain injuryspinal cord injuryseizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorderscerebrovascular accident (stroke)Parkinson's diseasemultiple sclerosismyasthenia gravisHuntington's disease; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of physical and psychological addictionsgambling addictioneating disorders and addictionsnicotine addictionInternet addictiondrug addiction; pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disordersanxietymood disordersschizophreniacognitive and bipolar disordersepilepsyAlzheimer'scerebral palsyParkinson's diseasemultiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseasesmood disordersanxiety disorderscognitive disordersschizophrenia; pharmaceutical preparations for the treatment of respiratory diseasesdisorders and infections; pharmaceutical preparations for the treatment of skin irritationsbee stingssunburnrashessorescornscallusesacne; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous systemcentral nervous system infectionsbrain diseasescentral nervous system movement disordersocular motility disordersspinal cord diseases; pharmaceutical preparations for the treatment of the central nervous systemencephalitisepilepsyAlzheimer'scerebral palsyParkinson's disease; pharmaceutical preparations for the treatment of the diseasesdisorders and infections of the central nervous systembrainmovementocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal systemconnective tissue diseasesbone diseasesspinal diseasesback painfracturessprainscartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for the treatment of viral diseasesherpeshepatitisAcquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for use in dermatologydermatitisskin pigmentation diseasessexually transmitted diseases; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for wounds; pharmaceutical preparations against dry skin caused by pregnancy; pharmaceutical preparations for hydrating the skin during pregnancy; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for treating respiratory diseases; pharmaceutical solutions used in dialysis; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; sunburn preparations for pharmaceutical purposes; synthetic peptides for the treatment of all of the foregoing diseases and conditions; disinfection systemsall-purpose disinfectants; none of the foregoing for the treatment of cancer or oncological diseases and disorders
Classe 10
Drug delivery systemsneedlessyringesnasal spray bottlesinjection devicesoral and nasal inhalation devicespatch pumpsanesthetic delivery apparatus for medical purposesbut not for use in the fields of diabetes and obesity; none of the foregoing for the treatment of cancer or oncological diseases and disorders
Classe 35
Business consulting services relating to pharmaceutical manufacturingclinical evaluation and testingregulatory registrationstability studiesmethod developmentformal stabilityregistration batches and commercial production; none of the foregoing for the treatment of cancer or oncological diseases and disorders
Classe 40
Contract manufacturing of clinical batches of pharmaceuticals; Consulting services relating to pharmaceutical manufacturingbatch biological treatment batchespharmaceutical manufacturing; custom manufacture of pharmaceuticalsthe formulation of new dosage forms and the reformulation of existing drug products; none of the foregoing for the treatment of cancer or oncological diseases and disorders
Classe 42
Consulting services relating to the clinical testinginspectionresearch of pharmaceuticals; Consulting services relating to conducting pharmaceutical stability studies and formal stability studies; Consulting services relating to the development of chemical production methods; Consulting services relating to registration batch research and commercial pharmaceutical products development; Pharmaceutical drug development servicesthe formulation of new dosage forms and the reformulation of existing drug products; none of the foregoing for the treatment of cancer or oncological diseases and disorders
Classe 45
Consulting services to assist companies with obtaining regulatory compliance and licenses for pharmaceuticals and medical devices; Consulting services relating to pharmaceuticals relating to regulatory compliance in the field of pharmaceuticalsregulatory registration; none of the foregoing for the treatment of cancer or oncological diseases and disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
62 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
21/05/2024
TMBN
TTAB RELEASE CASE TO TRADEMARKS
16/04/2024
OP.T
OPPOSITION TERMINATED NO. 999999
16/04/2024
OP.D
OPPOSITION DISMISSED NO. 999999
16/04/2024
OP.I
OPPOSITION INSTITUTED NO. 999999
04/10/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
26/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/04/2023
ALIE
ASSIGNED TO LIE
25/04/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/04/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
20/01/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
20/01/2023
CNSI
SUSPENSION INQUIRY WRITTEN
20/01/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
18/01/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
23/05/2022
GNSL
LETTER OF SUSPENSION E-MAILED
23/05/2022
CNSL
SUSPENSION LETTER WRITTEN
23/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/05/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
17/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
23/11/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
23/11/2021
CNSI
SUSPENSION INQUIRY WRITTEN
23/11/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
18/11/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
17/05/2021
GNSL
LETTER OF SUSPENSION E-MAILED
17/05/2021
CNSL
SUSPENSION LETTER WRITTEN
17/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/05/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
14/05/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
30/11/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
30/11/2020
CNSI
SUSPENSION INQUIRY WRITTEN
30/11/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
13/11/2020
ALIE
ASSIGNED TO LIE
02/11/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/02/2020
GNSL
LETTER OF SUSPENSION E-MAILED
28/02/2020
CNSL
SUSPENSION LETTER WRITTEN
28/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/02/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/09/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/09/2019
CNSL
SUSPENSION LETTER WRITTEN
03/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/03/2019
GNRT
NON-FINAL ACTION E-MAILED
13/03/2019
CNRT
NON-FINAL ACTION WRITTEN
13/03/2019
DOCK
ASSIGNED TO EXAMINER
07/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/12/2018
NWAP
NEW APPLICATION ENTERED
11/12/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOVOCOL PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.